RAF1 and cancer: The paradoxical activation of RAF–MEK–ERK signaling driven by RAF inhibitors is not only responsible for the intrinsic resistance of Ras-mutated cancers but also one of the important causes that lead to acquired resistance in BRAFV600E-harboring cancers (32).